BioStrategy Partners

A new study involving researchers from Children’s Hospital of Philadelphia has identified immune biomarkers in patients with acute myeloid leukemia (AML) that can help predict which patients will be resistant to chemotherapy and which might benefit from a new immunotherapy. Full Story

Professor of Evolutionary Genomics Sergei Pond is on the lookout for mutations in the DNA of the coronavirus. Full Story

The micronutrient zinc administered orally as zinc gluconate (an over-the-counter lozenge) may help to prevent cancer of the esophagus in patients diagnosed with the pre-malignant condition called Barrett’s esophagus (BE), according to the results of a first-ever pilot study in humans conducted, in part, by investigators at the Lankenau [...]

Michael Baram, MD, and other pulmonary researchers at Thomas Jefferson University partnered with the Jefferson Clinical Research Institute (JCRI) to get one of the first COVID-19 related clinical trials up and running in record time at Thomas Jefferson University. Full Story

Young patients with no risk factors for stroke may have an increased risk if they have contracted COVID-19, whether or not they are showing symptoms of the disease. Surgeons at Thomas Jefferson University and collaborators analyzed patients presenting with stroke from March 20th until April 10th at their institutions. [...]